We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Convatec Group Plc | LSE:CTEC | London | Ordinary Share | GB00BD3VFW73 | ORD 10P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -15.60 | -5.66% | 260.00 | 259.80 | 260.20 | 268.40 | 255.80 | 267.80 | 6,608,515 | 14:41:41 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Med, Dental, Hosp Eq-whsl | 2.14B | 130.3M | 0.0636 | 40.79 | 5.32B |
From Apr 2019 to Apr 2024
TIDMCTEC
RNS Number : 6893M
ConvaTec Group PLC
18 September 2019
Acquisition of Southlake Medical Supplies
18 September 2019 (LSE: CTEC)
ConvaTec Group Plc ("ConvaTec"), a leading global medical products and technologies company, today announces it has signed an agreement to purchase the assets of Southlake Medical Supplies, Inc. ("Southlake"), a Texas-based independent provider of catheter-related supplies. For the year ended 31 December 2018 Southlake delivered revenues of approximately $5.0 million.
The acquisition is expected to close on 30 September, subject to the usual formalities.
Rick Anderson, Executive Chairman of ConvaTec, said: "The addition of Southlake to our Home Distribution Group will further strengthen our presence in an important U.S. market. We look forward to bringing our distinctive service and personal support to even more customers, as the leading supplier of urinary catheters in the US."
Enquiries:
John Crosse, VP Investor Relations +44 (0)7500 141435 Mark Reynolds, Director Investor Relations investorrelations@convatec.com +44 (0)7551 036625 Finsbury +44 (0)207 2513801
About ConvaTec
ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com where a copy of this announcement can also be found.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
ACQEAANXFDDNEAF
(END) Dow Jones Newswires
September 18, 2019 02:01 ET (06:01 GMT)
1 Year Convatec Chart |
1 Month Convatec Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
